Webinar 01: GLP-1 and Nutrition: General Recommendations

Valery Rivera Hiraldo, LND, discussed statistics related to the use of medications for weight management and presented the main medications currently available, including semaglutide, liraglutide, dulaglutide, tirzepatide, and orforglipron. She also addressed key elements of the consensus and the patient pathway for individuals using GLP-1 receptor agonists, including the initial evaluation before treatment, nutrition during the weight-loss phase, management of gastrointestinal symptoms, the importance of physical activity, and nutritional strategies during the weight-maintenance phase. Disclosure This project is supported by grant number UU754330 from the Health Resources and Services Administration (HRSA) of U.S. Department of Health and Human Services (HHS) as part of an award totaling $474,953.00 for this period with 0% financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor and endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov. The initiative was awarded to the Puerto Rico Science, Technology and Research Trust and will be developed by the Puerto Rico Public Health Trust.